Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 11561866)

1.

Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.

Desser L, Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S10-5.

PMID:
11561866
2.

Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.

Paczek L, Gaciong Z, Bartlomiejczyk I, Sebekova K, Birkenmeier G, Heidland A.

Drugs Exp Clin Res. 2001;27(4):141-9.

PMID:
11822224
3.

Modulation of growth factor binding properties of alpha2-macroglobulin by enzyme therapy.

Lauer D, Müller R, Cott C, Otto A, Naumann M, Birkenmeier G.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S4-9.

PMID:
11561872
4.

Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.

Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G.

Prostate. 2004 Nov 1;61(3):201-8.

PMID:
15368477
5.

Alpha 2-macroglobulin-mediated degradation of amyloid beta 1--42: a mechanism to enhance amyloid beta catabolism.

Lauer D, Reichenbach A, Birkenmeier G.

Exp Neurol. 2001 Feb;167(2):385-92.

PMID:
11161627
6.

Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.

Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.

Eur Cytokine Netw. 2001 Jul-Sep;12(3):445-52.

PMID:
11566625
7.

Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.

Sakaguchi K, Kitano M, Nishimura M, Senoh T, Ohta T, Terao M, Shinji N, Koide N, Tsuji T.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1780-3.

PMID:
15532825
9.

ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.

Shin GT, Kim SJ, Ma KA, Kim HS, Kim D.

Am J Kidney Dis. 2000 Nov;36(5):894-902.

PMID:
11054345
10.

Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.

Cho ML, Min SY, Chang SH, Kim KW, Heo SB, Lee SH, Park SH, Cho CS, Kim HY.

Immunol Lett. 2006 Jun 15;105(2):159-66. Epub 2006 Mar 3.

PMID:
16564576
12.

The concentration of serum transforming growth factor beta-1 (TGF-beta1) is decreased in cervical carcinoma patients.

Wu HS, Li YF, Chou CI, Yuan CC, Hung MW, Tsai LC.

Cancer Invest. 2002;20(1):55-9.

PMID:
11853003
15.

Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.

Lin Y, Kikuchi S, Obata Y, Yagyu K; Tokyo Research Group on Prevention of Gastric Cancer.

J Gastroenterol Hepatol. 2006 Feb;21(2):432-7.

PMID:
16509870
16.

TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.

Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos-Kudla B, Strzalka B, Fila A, Niedziolka D, Beniowski M, Ostrowska Z, Borgiel-Marek H, Kajdaniuk J, Sieminska L, Nowak M, Wilczok T, Pakula D, Filipczyk P.

J Clin Pharm Ther. 2005 Jun;30(3):271-7.

PMID:
15896245
17.
18.

Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations.

Desser L, Rehberger A, Kokron E, Paukovits W.

Oncology. 1993 Nov-Dec;50(6):403-7.

PMID:
7694216
19.

Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.

Stefoni S, Cianciolo G, Donati G, Dormi A, Silvestri MG, Colì L, De Pascalis A, Iannelli S.

Kidney Int. 2002 Jan;61(1):324-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk